Optometry - Journal of the American Optometric Association
Volume 81, Issue 9 , Pages 454-460 , September 2010

On the frontline: What an optometrist needs to know about myasthenia gravis

  • Joseph A. Pruitt, O.D.

      Affiliations

    • Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
    • University of Missouri-Saint Louis College of Optometry, Saint Louis, Missouri
    • Corresponding Author InformationCorresponding author: Joseph A. Pruitt, O.D., Minneapolis Veterans Affairs Medical Center, 1 Veterans Drive (100-77), Minneapolis, Minnesota 55417.
    • ,
  • Pauline F. Ilsen, O.D.

      Affiliations

    • Southern California College of Optometry, Fullerton, California
    • West Los Angeles Veterans Affairs Healthcare Center, Los Angeles, California

References 

  1. Colavito J, Cooper J, Ciuffreda K. Non-ptotic ocular myasthenia gravis: a common presentation of an uncommon disease. Optometry 76(7): 363-75.
  2. National Institute of Neurological Disorders and Stroke Publication 99-768. Available at: http://www.ninds.nih.gov/disorders/myasthenia_gravis/myasthenia_gravis.htm. Last accessed April 15, 2008.
  3. Donati F, Bevan D. Neuromuscular blocking agents. In: Clinical Anesthesia. ed 5. Chapter 16. Lippincott Williams & Wilkins; 2006;
  4. Palace J, Vincnet A, Beeson D. Myasthenia gravis: diagnostic and management dilemmas. Curr Opin Neurol. 2001;14:583–589
  5. Homel P, Kupersmith M. Development of generalized myasthenia gravis in patients with ocular myasthenia gravis. Arch Neurol. 2003;60(10):1491–1492
  6. Toyka K. Ptosis in myasthenia gravis: extended fatigue and recovery bedside test. Neurology. 2006;67(8):1524
  7. Reddy A, Backhouse O. “Ice-on-eyes,” a simple test for myasthenia gravis presenting with ocular symptoms. Practical Neurology. 2007;7(2):109–111
  8. Benatar M, Kaminski H. Evidence report: The medical treatment of ocular myasthenia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2007;68(24):2144–2149
  9. Rudnicki S. Lamber-Eaton Myasthenic syndrome with pure ocular weakness. Neurology. 2007;68(21):1863–1864
  10. Rowland R, Sparr S. Head-drop and shortness of breath as a presentation of myasthenia gravis. J Am Geriatr Soc. 2007;55(4):S116
  11. Hilton-Jones D, Palace J. The management of myasthenia gravis. Practical Neurology. 2005;5:18–27
  12. Golnik K. How to diagnose and treat myasthenia gravis. Rev Ophthalmol. 2002;9(10):219
  13. Scherer K, Bedlack R, Simel D. Does this patient have myasthenia gravis?. JAMA. 2005;293(15):1906–1914
  14. Morris O, O'day J. Fatiguable ptosis and pseudoretraction caused by myasthenia gravis. Clin Exp Ophthalmol. 2004;32:303–304
  15. Shaw J. When muscles falter: update on myasthenia gravis. Clinical update: neuro-opthalmology. Available at: http://www.aao.org/publications/eyenet/200607/neuro.cfm. 2006. Last accessed November 12, 2009
  16. Golnik K, Pena R, Lee A, et al. An ice test for the diagnosis of myasthenia gravis. Ophthalmology. 1999;106(7):1282–1286
  17. Ubogu E, Kaminski H. The preferential involvement of extraocular muscle by myasthenia gravis. Neuro-ophthalmology. 2001;25(4):219–228
  18. Kennard C. Examine eye movements. Practical Neurology. 2007;7:326–330
  19. Chan J, Orrison W. Ocular myasthenia: a rare presentation with MuSK antibody and bilateral extraocular muscle atrophy. Br J Ophthalmol. 2007;91:842–843
  20. Kubis K, Danesh-Meyer H, Savino P, et al. The ice test versus the rest test in myasthenia gravis. Ophthalmology. 2000;107(11):1995–1998
  21. Gilbert M, De Sousa E, Savino P, et al. Ocular myasthenia gravis treatment: the case against prednisone therapy and thymectomy. Arch Neurol. 2007;64(12):1790–1792
  22. Chavis P, Stickler D, Walker A. Immunosuppressive or surgical treatment for ocular myasthenia gravis. Arch Neurol. 2007;64(12):1792–1794
  23. Kupersmith M, Latkany R, Homel P. Development of generalized disease at 2 years in patients with ocular myasthenia gravis. Arch Neurol. 2003;60(2):243–248
  24. Kaminski H, Daroff R. Treatment of ocular myasthenia: steroids only when compelled. Arch Neurol. 2000;57(5):752–753
  25. Bennett D, Mills K, Riordan-Eva P, et al. Anti-MuSK antibodies in a case of ocular myasthenia gravis. J Neurol Neurosurg Psychiatry. 2006;77(4):564–565
  26. Sommer N, Sigg B, Melms A, et al. Ocular myasthenia gravis: response to long term immunosuppressive treatment. J Neurol Neurosurg Psychiatry. 1997;62(2):156–162
  27. Glaser J. Infranuclear disorders of eye movements. In:  Tasman W,  Jaeger EA editor. Duane's clinical ophthalmology. Philadelphia: Lippincott-Raven; 1995;p. 1–56
  28. Howard J. Intravenous immunoglobulin for the treatment of acquired myasthenia gravis. Neurology. 1998;51(6):Suppl. 5:S30–S36
  29. Hilkevich O, Drory V, Chapman J, et al. The use of intravenous immunoglobulin as maintenance therapy in myasthenia gravis. Clin Neuropharmacol. 2001;24(3):173–176
  30. Meche F, Schmitz P. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillian-Barre syndrome. Dutch Guillian-Barre Study Group. N Engl J Med. 1992;326(17):1123–1129
  31. Roberts P, Venuta F, Rendina E, et al. Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg. 2001;122(3):562–568
  32. Lauriola L, Ranelletti F, Maggiano N, et al. Thymus changes in anti-MuSK-positive and –negative myasthenia gravis. Neurology. 2005;64(3):536–538
  33. Mori T, Nomori H, Ikeda K, et al. The distribution of parenchyma, follicles, and lymphocyte subsets in thymus of patients with myasthenia gravis, with special reference to remission after thymectomy. J Thorac Cardiovasc Surg. 2007;133(2):364–368
  34. Bachmann K, Burkhardt D, Schreiter I, et al. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement. Surgery. 2009;145:392–398
  35. Agius M. Treatment of ocular myasthenia with corticosteroids: yes. Arch Neurol. 2000;57(4):750–751
  36. Morris O, O'Day J. Strabismus Surgery in the management of diplopia caused by myasthenia gravis. Br J Ophthalmol. 2004;88:832–850
  37. Bienfang DC. Neuroophthalmology. In:  Samuels MA editors. Manual of neurologic therapeutics. Ed 7.. Philadelphia: Lippincott Williams & Wilkins; 2004;
  38. Calvert PC. Disorders of neuromuscular transmission: myasthenia gravis. In:  Miller NR,  Newman NJ editor. Walsh & Hoyt's clinical neuro-ophthalmology. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 1059–1065
  39. Penn AS, Rowland MP. Myasthenia gravis. In:  Rowland MP editors. Merritt's neurology. Ed 11.. Philadelphia: Lippincott Williams & Wilkins; 2005;p. 877–884
  40. Amato MM, Monheit B, Shore JW. Neuro-ophthalmology; examination of the ptosis patient. In:  Tasman W editors. Duane's clinical ophthalmology. vol. 5:Philadelphia: Lippincott, Williams, & Wilkins; 2009;
  41. Periman L, Sires B. Floppy eyelid syndrome: a modified surgical technique. Ophthalm Plast Reconstruct Surg. 2002;18(5):370–372
  42. Sakol P, Mannor G, Massaro B. Congenital and acquired blepharoptosis. Curr Opin Ophthalmol. 1999;10:335–339
  43. Shields M, Putterman A. Blepharoptosis correction. Curr Opin Otolaryngol Head Neck Surg. 2003;11(4):261–266
  44. Eliasoph I. RE: “Surgical correction of blepharoptosis in patients with myasthenia gravis.”. Opththal Plast Reconstr Surg. 2002;18(4):312–313
  45. McCord C, Seify H, Codner M. Transblepharoplasty ptosis repair: three-step technique. Plast Reconstruct Surg. 2007;120(4):1037–1044
  46. Seider N, Beiran I, Kaltreider S. One medial triangular Tutoplast sling as a frontalis suspension for adult myogenic blepharoptosis. Acta Ophthalmologica Scand. 2006;84:121–123
  47. Wong V, Beckingsale P, Olley C, et al. Management of myogenic ptosis. Ophthalmology. 2002;109(5):1023–1031
  48. Bernardini F, Concillis C, Devoto M. Frontalis suspension sling using a silicone rod in patients affected by myogenic blepharoptosis. Orbit. 2002;21(3):195–198
  49. Gausas R, Goldstein S. Ptosis in the elderly patient. Int Ophthalmol Clin. 2002;42(2):61–74
  50. Lapid O. Eyelid crutches for ptosis: a forgotten solution. Plast Reconstruct Surg. 2000;106(5):1213–1214
  51. Takagi S, Hosokawa K, Yano K, et al. Crutches glasses for blepharoptosis. Plast Reconstruct Surg. 2002;109(7):2605
  52. Bamford CR. Myasthenia gravis. In:  Domino FJ editors. The 5-minute clinical consult. Philadelphia: Lippincott, Williams, & Wilkins; 2007;p. 808–809
  53. Mazzoni P, Pearson TS, Rowland, LP, ed. Myasthenia gravis. In: Merritt's neurology handbook, Ed 2. Philadelphia: Lippincott, Williams, & Wilkins, 2006: 507–510.
  54. Loh A. Myasthenia gravis. In:  Schaider J,  Hayden SR,  Wolfe R, et al. editor. Rosen & Barkin's 5-minute emergency medicine consult. Ed 3.. Philadelphia: Lippincott, Williams, & Wilkins; 2007;p. 718–719

PII: S1529-1839(10)00334-9

doi: 10.1016/j.optm.2009.09.023

Optometry - Journal of the American Optometric Association
Volume 81, Issue 9 , Pages 454-460 , September 2010

Article Tools